VijayShahMD

Gastroenterology • Rochester, MN

Biliary Tract Disease, Hepatology & Liver Transplantation

Professor, Internal Medicine, Mayo Medical School

Join to view full profile

Dr. Shah is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Shah's full profile

Already have an account?

Office
200 1st St Sw
Rochester, MN 55905
Phone+1 507-284-2511

Education & Training

Yale-New Haven Medical CenterFellowship, Gastroenterology, 1994 - 1997
McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1994
Northwestern University The Feinberg School of MedicineClass of 1991

Certifications & Licensure

MN State Medical License 1998 - 2025
IL State Medical License 1991 - 1996
American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

Elected Member The American Society for Clinical Investigation, 2011
Fellow (FACG) American College of Gastroenterology

Clinical Trials

Safety and Efficacy of IMM 124-E for Patients With Severe Alcoholic Hepatitis Start of enrollment: 2014 Dec 01
Completed
Phase 2
Trial of Obeticholic Acid in Patients With Moderately Severe Alcoholic Hepatitis (AH) Start of enrollment: 2014 Nov 03
Terminated
Phase 2
Alcoholic Hepatitis: A Multicenter, Observational Study by the TREAT Consortium Start of enrollment: 2013 Jun 01
Completed
Use of F-652 in Patients With Alcoholic Hepatitis Start of enrollment: 2016 Feb 01
Completed
Phase 1, Phase 2
Trial of Anakinra (Plus Zinc) or Prednisone in Patients With Severe Alcoholic Hepatitis Start of enrollment: 2020 Jul 10
Completed
Phase 2
Liver Cirrhosis Network Cohort Study Start of enrollment: 2022 Nov 14
Recruiting
Roles: Contact
Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States Start of enrollment: 2023 Oct 11
Recruiting
Phase 2
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

2 citations
An artificial intelligence-generated model predicts 90-day survival in alcohol-associated hepatitis: A global cohort study.
Winston Dunn, Yanming Li, Ashwani K Singal, Douglas A Simonetto, Luis A Díaz
Hepatology. 2024-11-01
Artificial Intelligence, Large Language Models, and Digital Health in the Management of Alcohol-Associated Liver Disease.
Neeraj Bhala, Vijay H Shah
Clinics in Liver Disease. 2024-11-01
4 citations
Racial and ethnic disparities in the natural history of alcohol-associated liver disease in the United States.
Gustavo Ayares, Luis Antonio Díaz, Eduardo Fuentes-López, Francisco Idalsoaga, Thomas G Cotter
Liver International. 2024-10-01

Lectures

Evaluation of a Patient With Alcoholic Liver Disease
AGC 2018 Annual Scientific Meeting, Philadelphia, PA - 10/9/2018
grand rounds
mayo clinic - 1/4/2014

Authored Content

Alcohol-Associated Liver Disease: A Global Problem in Need of Global SolutionsJune 2021

Press Mentions

Identifying, Treating Alcohol-Associated Liver Disease in Women Requires Change in MindsetOctober 28th, 2024
Meet Yan Bi, M.D., Ph.D. — Physician and ScholarSeptember 1st, 2022
Minnesota Partnership Awards Five Collaborative Research Grants for 2022January 13th, 2022
Join now to see all

Professional Memberships

American College of Gastroenterology - ACG
Fellow